Indivior (INDV) CSO gains 101,544 shares, withholds 45,797 for tax

Filing Impact

(Very High)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Indivior Pharmaceuticals, Inc. Chief Scientific Officer Christian Heidbreder had performance stock units granted on March 3, 2023 vest on March 3, 2026 after performance conditions were determined to be met at 76.6%. This resulted in 101,544 shares of common stock vesting out of a 132,565 target amount, with each unit representing one share. To cover tax withholding related to this vesting, 45,797 shares of common stock were disposed of at $31.98 per share. Following these transactions, Heidbreder directly held 246,509 shares of Indivior common stock.

Insider Trade Summary

132,565 shares exercised/converted

Mixed 3 txns

Insider Heidbreder Christian

Role Chief Scientific Officer

Type	Security	Shares	Price	Value
Exercise	Performance Stock Units	132,565	$0.00	--
Exercise	Common Stock	101,544	$0.00	--
Tax Withholding	Common Stock	45,797	$31.98	$1.46M

Holdings After Transaction: Performance Stock Units — 0 shares (Direct); Common Stock — 292,306 shares (Direct)

Footnotes (1)

Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 101,544 shares vested out of the 132,565 target amount. Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock. Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

03/05/2026 - 03:59 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Heidbreder Christian

(Last)

(First)

(Middle)

10710 MIDLOTHIAN TURNPIKE

SUITE 125

(Street)

NORTH CHESTERFIELD

23235

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Indivior Pharmaceuticals, Inc. [ INDV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Scientific Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/03/2026		M		101,544⁽¹⁾	A	⁽²⁾	292,306	D
Common Stock	03/03/2026		F		45,797⁽³⁾	D	$31.98	246,509	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Performance Stock Units	$0⁽²⁾	03/03/2026		M			132,565	03/03/2026⁽¹⁾	⁽¹⁾	Common Stock	132,565	⁽²⁾	0	D

Explanation of Responses:

1. Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 101,544 shares vested out of the 132,565 target amount.

2. Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.

3. Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026.

Remarks:

	/s/Alice Givens, Power of Attorney	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Indivior (INDV) report for Christian Heidbreder?

Indivior reported that Chief Scientific Officer Christian Heidbreder had performance stock units vest into 101,544 shares of common stock. The vesting followed a performance assessment and was partly offset by shares withheld to cover tax obligations.

How many Indivior (INDV) performance stock units vested for the CSO?

Performance stock units vested into 101,544 shares of Indivior common stock for the Chief Scientific Officer. These shares came from a 132,565-unit target award granted on March 3, 2023, after performance conditions were determined to be 76.6% achieved.

What does each Indivior (INDV) performance stock unit represent in this Form 4?

Each performance stock unit represents a contingent right to receive one share of Indivior common stock. When the performance conditions were met at 76.6%, a portion of the original 132,565 target units converted into 101,544 common shares for the executive.

How many Indivior (INDV) shares were used to satisfy tax withholding?

A total of 45,797 shares of Indivior common stock were used to satisfy tax withholding obligations. These shares were disposed of at a price of $31.98 per share in connection with the March 3, 2026 vesting of performance stock units.

What is Christian Heidbreder’s Indivior (INDV) shareholding after these transactions?

After the vesting and related tax-withholding disposition, Christian Heidbreder directly held 246,509 shares of Indivior common stock. This balance reflects the newly vested shares net of the shares delivered to cover tax obligations associated with the award.

When were the Indivior (INDV) performance stock units originally granted and when did they vest?

The performance stock units were originally granted to the executive on March 3, 2023. They vested on March 3, 2026 after performance conditions were determined to be 76.6% achieved, leading to 101,544 common shares being issued from the target award.